Bayer Aktiengesellschaft (ETR:BAYN) Stock Price Down 1.9% – Time to Sell?

Bayer Aktiengesellschaft (ETR:BAYN)’s share price was down 1.9% during trading on Wednesday . The company traded as low as €36.88 and last traded at €37.74. Approximately 3,185,697 shares changed hands during mid-day trading, The stock had previously closed at €38.47.

Bayer Aktiengesellschaft Stock Down 1.9%

The firm has a 50-day moving average of €42.55 and a two-hundred day moving average of €34.88. The firm has a market cap of $38.10 billion, a price-to-earnings ratio of -43.30, a PEG ratio of 36.39 and a beta of 0.93. The company has a current ratio of 1.00, a quick ratio of 0.72 and a debt-to-equity ratio of 144.30.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.